Live Breaking News & Updates on European Regulatory

Stay updated with breaking news from European regulatory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript

Novo Nordisk A/S misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.77. ....

United States , Doug Langa , Michael Nedelcovych , Martin Holst Lange , Richard Vosser , Daniel Muusmann Bohsen , Camilla Sylvest , Daniel Bohsen , Lars Fruergaard , Novo Nordisk , Karsten Munk Knudsen , Louise Chen , European Renal Association Congress , Catalenta Global Contract Development , Cardior Pharmaceuticals , Novo Holdings , Head Of Development , Corporate Affairs , Manufacturing Organization , European Commission , Call Transcript May , Investor Relations , Executive Vice President , Commercial Strategy , North America Operations , Chief Financial Officer ,

Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic ...

Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic . ....

United States , Randy Milby , Tharimmune Inc , National Institute Of Diabetes , National Institutes Of Health , News Network , European Regulatory , Worst Itch Numerical Rating Scale , National Institute , Kidney Diseases , National Institutes ,

Tharimmune (THAR) Reports Positive Phase 1 Data on TH104

Tharimmune (THAR) Reports Positive Phase 1 Data on TH104
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Randy Milby , National Institute Of Diabetes , National Institutes Of Health , Tharimmune Inc , European Regulatory , Worst Itch Numerical Rating Scale , National Institute , Kidney Diseases , National Institutes ,

Tharimmune Shares Rise On Positive Phase 1 Data On TH104

Shares of Tharimmune, Inc. (THAR) are up 33% on Monday after the company announced positive phase 1 data for its proprietary transmucosal buccal film product, TH104, that adheres easily to the inside of the mouth, making it a convenient solution for patients. ....

United States , Tharimmune Inc , European Regulatory ,

EMA grants PRIME designation to Rocket's AAV-based gene therapy

The EMA has granted PRIME designation to Rocket’ adeno-associated virus (AAV)-based gene therapy, RP-A501, for the treatment of Danon Disease. ....

Kinnari Patel , York Heart Association , New York Heart Association , Kansas City Cardiomyopathy Questionnaire , European Regulatory ,